journal article·2016-01-13

Combined Effect of Cryogel Matrix and Temperature-Reversible Soluble–Insoluble Polymer for the Development of in Vitro Human Liver Tissue

Jyoti Kumari, Anjali A. Karande, Ashok Kumar

Publisher page

Abstract

Hepatic cell culture on a three-dimensional (3D) matrix or as a hepatosphere appears to be a promising in vitro biomimetic system for liver tissue engineering applications. In this study, we have combined the concept of a 3D scaffold and a spheroid culture to develop an in vitro model to engineer liver tissue for drug screening. We have evaluated the potential of poly(ethylene glycol)-alginate-gelatin (PAG) cryogel matrix for in vitro culture of human liver cell lines. The synthesized cryogel matrix has a flow rate of 7 mL/min and water uptake capacity of 94% that enables easy nutrient transportation in the in vitro cell culture. Young's modulus of 2.4 kPa and viscoelastic property determine the soft and elastic nature of synthesized cryogel. Biocompatibility of PAG cryogel was evaluated through MTT assay of HepG2 and Huh-7 cells on matrices. The proliferation and functionality of the liver cells were enhanced by culturing hepatic cells as spheroids (hepatospheres) on the PAG cryogel using temperature-reversible soluble-insoluble polymer, poly(N-isopropylacrylamide) (PNIPAAm). Pore size of the cryogel above 100 μm modulated spheroid size that can prevent hypoxia condition within the spheroid culture. Both the hepatic cells have shown a significant difference (P < 0.05) in terms of cell number and functionality when cultured with PNIPAAm. After 10 days of culture using 0.05% PNIPAAm, the cell number increased by 11- and 7-fold in case of HepG2 and Huh-7 cells, respectively. Similarly, after 10 days of hepatic spheroids culture on PAG cryogel, the albumin production, urea secretion, and CYP450 activity were significantly higher in case of culture with PNIPAAm. The developed tissue mass on the PAG cryogel in the presence of PNIPAAm possess polarity, which was confirmed using F-actin staining and by presence of intercellular bile canalicular lumen. The developed cryogel matrix supports liver cells proliferation and functionality and therefore can be used for in vitro and in vivo drug testing.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Hydrogels: synthesis, properties, applications · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, 208016 UP, India

Department of Biochemistry, Indian Institute of Sciences, Bangalore 560012, India

Funding

Department of Biotechnology , Ministry of Science and Technology · Department of Science and Technology, Ministry of Science and Technology

References (63)

Show source-provided references
1. 10.1016/S0002-9440(10)63352-410.1016/S0002-9440(10)63352-4 ↗
2. 10.1007/978-1-60761-688-7_2710.1007/978-1-60761-688-7_27 ↗
3. 10.1371/journal.pone.007855010.1371/journal.pone.0078550 ↗
4. 10.1073/pnas.110179110810.1073/pnas.1101791108 ↗
5. 10.1080/0363904050021624610.1080/03639040500216246 ↗
6. 10.1258/00236770677761146010.1258/002367706777611460 ↗
7. 10.1016/j.jhep.2013.01.00910.1016/j.jhep.2013.01.009 ↗
8. 10.1007/s00204-013-1078-510.1007/s00204-013-1078-5 ↗
9. 10.1083/jcb.105.1.54110.1083/jcb.105.1.541 ↗
10. 10.1046/j.1365-2613.1998.00083.x10.1046/j.1365-2613.1998.00083.x ↗
11. 10.2174/18722080978870020110.2174/187220809788700201 ↗
12. 10.1016/j.bej.2009.10.00310.1016/j.bej.2009.10.003 ↗
13. Bhatia S. N. · FASEB J. · 1999 · 13 · 188310.1096/fasebj.13.14.1883 ↗
14. 10.1046/j.1432-0436.2003.7104503.x10.1046/j.1432-0436.2003.7104503.x ↗
15. 10.1177/221106821455781310.1177/2211068214557813 ↗
16. 10.1021/bm401503910.1021/bm4015039 ↗
17. 10.1371/journal.pone.005370810.1371/journal.pone.0053708 ↗
18. 10.1016/j.tibtech.2003.08.00210.1016/j.tibtech.2003.08.002 ↗
19. 10.1016/j.actbio.2008.07.00910.1016/j.actbio.2008.07.009 ↗
20. 10.1021/am504652y10.1021/am504652y ↗
21. 10.1016/S0142-9612(01)00399-410.1016/S0142-9612(01)00399-4 ↗
22. 10.1021/am502958210.1021/am5029582 ↗
23. 10.1016/j.tibtech.2004.02.00210.1016/j.tibtech.2004.02.002 ↗
24. 10.1002/bit.1065510.1002/bit.10655 ↗
25. 10.1089/ten.2006.12.215110.1089/ten.2006.12.2151 ↗
26. 10.1089/ten.tea.2012.013910.1089/ten.tea.2012.0139 ↗
27. 10.1111/j.1749-6632.1997.tb52213.x10.1111/j.1749-6632.1997.tb52213.x ↗
28. 10.1016/j.carbpol.2010.05.01110.1016/j.carbpol.2010.05.011 ↗
29. 10.1007/s10856-011-4512-310.1007/s10856-011-4512-3 ↗
30. 10.1016/j.biomaterials.2004.08.01710.1016/j.biomaterials.2004.08.017 ↗
31. 10.1517/17425255.2.2.18310.1517/17425255.2.2.183 ↗
32. 10.1089/ten.tea.2007.043410.1089/ten.tea.2007.0434 ↗
33. 10.1007/s10856-011-4323-610.1007/s10856-011-4323-6 ↗
34. 10.1021/la102917c10.1021/la102917c ↗
35. 10.1016/j.eurpolymj.2003.11.00410.1016/j.eurpolymj.2003.11.004 ↗
36. 10.1016/j.msea.2007.03.05710.1016/j.msea.2007.03.057 ↗
37. 10.1016/j.enzmictec.2010.07.01810.1016/j.enzmictec.2010.07.018 ↗
38. 10.1007/s10856-012-4795-z10.1007/s10856-012-4795-z ↗
39. 10.1111/j.1469-7580.2007.00778.x10.1111/j.1469-7580.2007.00778.x ↗
40. Marsh W. H. · Clin. Chem. · 1965 · 11 · 62410.1093/clinchem/11.6.624 ↗
41. 10.1016/j.jim.2003.09.01710.1016/j.jim.2003.09.017 ↗
42. 10.1002/tox.102210.1002/tox.1022 ↗
43. 10.1124/dmd.31.8.103510.1124/dmd.31.8.1035 ↗
44. 10.1021/bm100521x10.1021/bm100521x ↗
45. 10.1089/ten.tea.2012.004610.1089/ten.tea.2012.0046 ↗
46. 10.1091/mbc.E06-11-104010.1091/mbc.E06-11-1040 ↗
47. 10.1016/S0022-1759(01)00408-210.1016/S0022-1759(01)00408-2 ↗
48. 10.1089/ten.tec.2011.015010.1089/ten.tec.2011.0150 ↗
49. 10.1002/pi.294310.1002/pi.2943 ↗
50. 10.1021/jf903160310.1021/jf9031603 ↗
51. 10.1002/jbm.a.3212710.1002/jbm.a.32127 ↗
52. 10.1002/hep.2267410.1002/hep.22674 ↗
53. 10.1152/ajpgi.00032.200710.1152/ajpgi.00032.2007 ↗
54. 10.1109/58.48447810.1109/58.484478 ↗
55. 10.1002/hep.184012061510.1002/hep.1840120615 ↗
56. 10.1089/ten.tec.2009.005310.1089/ten.tec.2009.0053 ↗
57. 10.1089/ten.tea.2007.043410.1089/ten.tea.2007.0434 ↗
58. 10.3390/biom301024210.3390/biom3010242 ↗
59. 10.1007/BF0272294610.1007/BF02722946 ↗
60. 10.1016/j.progpolymsci.2007.05.00310.1016/j.progpolymsci.2007.05.003 ↗
61. 10.1021/am505444c10.1021/am505444c ↗
62. Busby W. F. · Drug Metab. Dispos. · 1999 · 27 · 24610.1016/S0090-9556(24)15284-1 ↗
63. Easterbrook J. · Drug Metab. Dispos. · 2001 · 29 · 141